Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Cash from Operations (2010 - 2026)

Incyte's (INCY) quarterly Cash from Operations came in at 507662000.0 in Q2 2026, up 1034.67% YoY from 44741000.0 in Q2 2025, and up 37.45% on a QoQ basis from 369351000.0 in Q1 2026.

Analysis

Incyte (INCY) Cash from Operations (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Cash from Operations data on file, last reported at 507662000.0 in Q2 2026.

  • Quarterly Cash from Operations rose 1034.67% year-over-year to 507662000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1979703000.0 (up 97.4% YoY) and the FY2025 annual result came in at 1413498000.0, up 321.52% from the prior year.
  • Cash from Operations climbed to 507662000.0 in Q2 2026, from 369351000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 559389000.0 in Q3 2025 to a low of 575563000.0 in Q2 2024.
  • A 5-year average of 227348666.67 and a median of 274864500.0 in 2022 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2024 — Cash from Operations sank 287.77% — and 2026, when it soared 1034.67%.
  • Tracing INCY's Cash from Operations over 5 years: stood at 283662000.0 in 2022, then slumped by 47.92% to 147729000.0 in 2023, then surged by 158.05% to 381218000.0 in 2024, then surged by 42.52% to 543301000.0 in 2025, then dropped by 6.56% to 507662000.0 in 2026.
  • The last three Cash from Operations figures came in at 507662000.0 (Q2 2026), 369351000.0 (Q1 2026), and 543301000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 507.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 507.66 Mn
Mar 31, 2026 369.35 Mn
Dec 31, 2025 543.30 Mn
Sep 30, 2025 559.39 Mn
Jun 30, 2025 44.74 Mn
Mar 31, 2025 266.07 Mn
Dec 31, 2024 381.22 Mn
Sep 30, 2024 310.87 Mn
Jun 30, 2024 -575.56 Mn
Mar 31, 2024 218.81 Mn
Dec 31, 2023 147.73 Mn
Sep 30, 2023 147.84 Mn
Jun 30, 2023 306.53 Mn
Mar 31, 2023 -105.60 Mn
Dec 31, 2022 283.66 Mn
Sep 30, 2022 296.38 Mn
Jun 30, 2022 174.16 Mn
Mar 31, 2022 215.74 Mn
Dec 31, 2021 115.35 Mn
Sep 30, 2021 255.10 Mn